Vancouver BC / NEWSWIRE / January 29, 2019 /CNW/ - (CSE: AGRO) (FSE: OSA) (WKN-A2N62K) ("Agrios" or the "Company") is pleased announce the appointment of Dr. M. Jill Clapperton to the advisory board of the Company.
Dr. Clapperton is an internationally respected scientist, agricultural educator, and highly sought-after speaker at both scientific and producer focused agricultural conferences around the world. Jill specializes in the development of analytical tools and research designs to simultaneously optimize both plant productivity and soil health.
For the past 25 years Dr. Clapperton has been involved in collaborative work with farmers and agriculture agencies in Canada, the United States, Europe, Australia, South and Central America, and Africa. She served as the Rhizosphere Ecologist for 16 years at Agriculture and Agri-Food Canada’s Lethbridge Research Centre in Lethbridge Alberta. Dr. Clapperton previously served as the Director of Research and Development for Groviv, a Nu Skin International company.
Dr. Clapperton is the founder and owner of Rhizoterra Inc., an international company based in the Pacific Northwest in Spokane, WA., whose research-based projects span multiple years and track a significant amount of agricultural data which is useful in predicting trends. Rhizoterra also has an interest in advancing hand held and portable laboratory analytical technology.
Dr. Clapperton is a member of the Soil Science Society of America, American Society of the Microbiology and the Association of Official Analytical Chemists (AOAC), and currently sits as an elected board member of the Pacific Northwest Direct Seed Association.
Chris Kennedy President & CEO of Agrios stated, “I am very pleased to welcome Jill to the advisory board of Agrios. Jill’s deep insights on data analyses and developing strategies to fine-tune equipment and cultivation processes for maximum efficiency is an excellent opportunity for Agrios to continue the advancement of its mandate. Agrios has long shared Jill’s interest in portable laboratory analytical technology, which enables the Company to offer on site laboratory testing services to its cultivating clients.”
About Agrios Global Holdings Ltd.
Agrios Global Holdings is a data analytics driven agriculture technology and services company advancing the latest innovations in indoor growing science. The Company owns, leases and manages properties and equipment for eco-sustainable agronomy and provides advisory services to support all aspects of aeroponic cultivation in the cannabis sector. Agrios is actively pursuing new opportunities to expand its portfolio of tenant growers and infrastructure assets in strategic licensed jurisdictions. Based in Vancouver, BC. Agrios is managed by a highly accomplished team of experienced industry and capital markets experts who are committed to the growth of the company.
For further information please contact:
Agrios Global Holdings Ltd.
This news release was prepared by management of Agrios, which takes full responsibility for its contents. The Canadian Securities Exchange (" CSE ") has not reviewed and does not accept responsibility for the adequacy of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Agrios' periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements related to corporate strategy and Agrios’ ability to execute such strategy, future developments regarding Agrios’ expansion into various markets including numerous states within the United States of America, and into Asia, expected costs of hemp fiber, intended development and sales of hemp products, market demand for hemp products, and the business and operations of Agrios as it relates to the Yunnan Province.
Although Agrios has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US Federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Agrios disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Agrios does not assume any liability for disclosure relating to any other company mentioned herein.